Clearcut phenotypic changes in peripheral blood lymphocytes (PBLs) were observed in all cancer diseases treated with “cellular therapy”: after the first cell vaccination, the increase of CTL CD8+, particularly CD8+11b−, was observed. Here, CD8A is linked to cancer.